Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh · Delayed Price · Currency is BDT 19.40
+0.10 (0.52%)
At close: Aug 13, 2026
DSE:IBP Market Cap
DSE:IBP has a market cap or net worth of 2.25 billion as of August 14, 2026. Its market cap has increased by 46.97% in one year.
Market Cap
2.25B
Enterprise Value
2.27B
Revenue
242.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.40
ChartMarket Cap Chart
Since October 18, 2018, DSE:IBP's market cap has decreased from 4.00B to 2.25B, a decrease of -43.64%. That is a compound annual growth rate of -7.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 2.25B | 70.18% |
| Dec 30, 2025 | 1.32B | 22.58% |
| Dec 30, 2024 | 1.08B | -50.79% |
| Dec 28, 2023 | 2.20B | 14.55% |
| Dec 29, 2022 | 1.92B | -1.34% |
| Dec 30, 2021 | 1.94B | -7.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| The IBN SINA Pharmaceutical Industry | 10.03B |
| Navana Pharmaceuticals | 7.45B |
| Orion Pharma | 6.72B |
| Techno Drugs | 5.98B |
| Silva Pharmaceuticals | 2.24B |
| Silco Pharmaceuticals | 2.13B |
| Pharma Aids | 1.91B |
| Ambee Pharmaceuticals | 1.90B |